 |
recombinant human lecithin:cholesterol acyltransferase (rhLCAT) |
|---|---|
| Trade Name | |
| Orphan Indication | Familial lecithin-cholesterol acyltransferase deficiency (FLD) |
| USA Market Approval | USA |
| USA Designation Date | 2010-09-02 00:00:00 |
| Sponsor | MedImmune;1 Medimmune Way;Gaithersburg, Maryland, 20878 |
